טוען...
Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review
INTRODUCTION: The epidermal growth factor receptor inhibitors (EGFRIs), cetuximab and panitumumab, represent an effective treatment option for patients affected by metastatic colorectal cancer (mCRC); furthermore, they are relatively devoid of systemic toxicities, which are commonly observed with st...
שמור ב:
Main Authors: | , , , , , , , , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Medknow Publications & Media Pvt Ltd
2013
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3853676/ https://ncbi.nlm.nih.gov/pubmed/24347989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.120966 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|